摘要
目的探究急性冠脉综合征患者血清白介素-6、基质金属蛋白酶2、CD40配体的水平变化及临床意义。方法选取2020年1月至10月厦门市第三医院心血管内科收治的50例急性ST段抬高型心肌梗死患者作为STEMI组,50例非ST段抬高型急性冠脉综合征患者作为NST-ACS组,另同期选择50名健康体检者作为对照组。比较三组的血清白介素-6、基质金属蛋白酶2、CD40配体水平。结果STEMI组血清白介素-6、基质金属蛋白酶2、CD40配体的水平均高于NST-ACS组、对照组,差异有统计学意义(P<0.05)。联合检测的阳性检出率高于其他单一指标,差异有统计学意义(P<0.008)。结论对急性冠脉综合征患者血清白介素-6、基质金属蛋白酶2、CD40配体的水平变化进行检测,能够对患者病变程度进行评价,利于后续治疗的开展,值得研究和推广。
Objective To investigate the changes and clinical significance of serum interleukin-6,matrix metalloproteinase 2 and CD40 ligand levels in patients with acute coronary syndrome.Methods A total of 50 patients with acute ST-segment elevation myocardial infarction admitted to the Department of Cardiovascular Medicine,Xiamen Third Hospital from January to October 2020 were selected as the STEMI group,and 50 patients with acute non-ST-segment elevation acute coronary syndrome were selected as the NST-ACS group,another 50 healthy subjects were selected as the control group during the same period.The levels of serum interleukin-6,matrix metalloproteinase 2 and CD40 ligand were compared among the three groups.Results The levels of serum interleukin-6,matrix metalloproteinase 2 and CD40 ligand in STEMI group were higher than those in NST-ACS group and control group,and the differences were statistically significant(P<0.05).The positive detection rate of combined detection was higher than that of other single indicators,and the difference was statistically significant(P<0.008).Conclusion The detection of serum interleukin-6,matrix metalloproteinase 2 and CD40 ligand levels in patients with acute coronary syndrome can evaluate the degree of lesions in patients and facilitate subsequent treatment.It is worthy of research and promotion.
作者
吴炜鹏
WU Weipeng(Department of Cardiovascular Medicine,Xiamen Third Hospital,Fujian Province,Xiamen361100,China)
出处
《中国当代医药》
CAS
2023年第4期78-81,共4页
China Modern Medicine